immune therapy takes bite brain cancer building research showing exciting new form immunotherapy cancer activity patients glioblastoma common deadly form brain cancer massachusetts general hospital mgh investigators created new method could make immune therapy effective brain tumors expand use types solid tumors study published journal nature biotechnology treatment known chimeric antigen receptor cell car therapy involves collecting genetically modifying patient immune fighting cells recognize specific targets antigens surface tumors returning patient car cell products approved fda treatment non hodgkin lymphoma acute lymphoblastic leukemia respectively cancers lymphatic system blood solid tumors glioblastoma notoriously difficult treat conventional cancer drugs drugs molecules large cross blood brain barrier immunotherapy problems area explains principal investigator marcela maus md ph director cellular immunotherapy mgh cancer center previously made car cells glioblastoma challenges glioblastoma tumor cells express target cell go says maus assistant professor medicine harvard medical school hms target aiming epidermal growth factor receptor variant iii egfrviii mutated cancer causing protein present surface many glioblastomas boost effectiveness car cells decided target antigen naturally occurring wild type egfr egfr present many cells body drugs targeting protein cause serious side effects overcome toxicity problem maus colleagues crafted car cell delivered cerebrospinal fluid base brain gets brain car secretes type immunotherapy called bi specific cell engager bite bites antibodies direct cell killing cells specific target somewhat akin homing mechanism called smart bomb smaller antibody based drugs bites large cross blood brain barrier intravenously bite secreting car construct crafted local tumor effect targeting antigen way overcoming tumor heterogeneity able target things produced side blood brain barrier small quantities cause toxicities organs maus says tested models human glioblastoma found modified bite secreting car ts eliminated tumors technique holds promise treating solid tumors says lead author bryan choi md department neurosurgery mgh biggest barrier face efforts bring research human clinical trials financial support investigators say